Xizang Haisco Pharmaceutical Group Co Ltd Cash Flow-to-Debt Ratio
Xizang Haisco Pharmaceutical Group Co Ltd cash flow-to-debt ratio. Xizang Haisco Pharmaceutical Group Co Ltd (002653) has a Cash Flow-to-Debt Ratio of 0.01x as of September 2025, meaning its operating cash flow of CN¥39.68 Million could theoretically repay 0% of its total liabilities (CN¥2.99 Billion) in one year. Check total reinvestment intensity of Xizang Haisco Pharmaceutical Group Co Lt to assess the company's total reinvestment commitment from operating cash flow.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Cash Flow-to-Debt Ratio of Xizang Haisco Pharmaceutical Group Co Ltd (2008–2025)
Cash flow-to-debt ratio of Xizang Haisco Pharmaceutical Group Co Ltd from 2008 to 2025. Historical debt coverage capacity for Xizang Haisco Pharmaceutical Group Co Ltd across 18 annual periods. Check how high is Xizang Haisco Pharmaceutical Group Co Lt's earnings quality to evaluate the quality of earnings relative to operating cash generation.
Xizang Haisco Pharmaceutical Group Co Ltd Cash Flow-to-Debt Ratio by Year (2008–2025)
Xizang Haisco Pharmaceutical Group Co Ltd cash flow-to-debt ratio by year from 2008 to 2025. Year-by-year debt coverage analysis for Xizang Haisco Pharmaceutical Group Co Ltd. For the full cash flow conversion analysis, see 002653 operating cash flow.
| Year | CF-to-Debt Ratio | Operating CF (CNY) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2025 | 0.29x | CN¥786.00 Million | CN¥2.72 Billion | ▲ +69.6% |
| 2024 | 0.17x | CN¥442.05 Million | CN¥2.60 Billion | ▼ -6.0% |
| 2023 | 0.18x | CN¥449.58 Million | CN¥2.48 Billion | ▲ +458.3% |
| 2022 | 0.03x | CN¥94.55 Million | CN¥2.91 Billion | ▲ +88.9% |
| 2021 | 0.02x | CN¥35.80 Million | CN¥2.09 Billion | ▼ -82.1% |
| 2020 | 0.10x | CN¥206.21 Million | CN¥2.15 Billion | ▼ -66.6% |
| 2019 | 0.29x | CN¥764.26 Million | CN¥2.66 Billion | ▲ +44.2% |
| 2018 | 0.20x | CN¥472.61 Million | CN¥2.37 Billion | ▲ +8.8% |
| 2017 | 0.18x | CN¥391.81 Million | CN¥2.14 Billion | ▼ -32.9% |
| 2016 | 0.27x | CN¥409.20 Million | CN¥1.50 Billion | ▼ -34.0% |
| 2015 | 0.41x | CN¥443.03 Million | CN¥1.07 Billion | ▼ -36.8% |
| 2014 | 0.65x | CN¥502.57 Million | CN¥767.55 Million | ▼ -38.9% |
| 2013 | 1.07x | CN¥568.41 Million | CN¥530.24 Million | ▼ -45.0% |
| 2012 | 1.95x | CN¥464.75 Million | CN¥238.49 Million | ▼ -14.1% |
| 2011 | 2.27x | CN¥260.79 Million | CN¥114.95 Million | ▲ +9.2% |
| 2010 | 2.08x | CN¥367.38 Million | CN¥176.79 Million | ▲ +20.9% |
| 2009 | 1.72x | CN¥368.21 Million | CN¥214.22 Million | ▲ +152.5% |
| 2008 | 0.68x | CN¥94.45 Million | CN¥138.73 Million | — |